Testosterone, COVID-19 and tadalafil


In this new video Professor Mike Kirby, Editor of Trends in Urology and Men’s Health, and Professor Geoff Hackett, Consultant in Sexual Medicine at Birmingham NHS Foundation Trust, discuss the results of recent research published on the association between testosterone and COVID-19.

As an adjunct to this discussion, the speakers also go over their recent article on the conflicting (and outdated) guidance currently used by Clinical Commissioning Groups on the regular prescription of tadalafil.

You can access the previous video, mentioned in this discussion, on the biological explanations for men’s vulnerability to serious COVID-19 infection here.  

Their article on the subject of testosterone and COVID-19 will be available in print and online soon. 

Comment (1) Add yours ↓
  1. David Nil

    Thank you for the insight as a person on TRT with comorbidities..Would be great to see a study involving patients currently.on TRT with primary hypogonadism.

    December 3, 2020 Reply

Your Comment

All comments are moderated. Trends in Urology & Men’s Health reserves the right not to publish material we deem inappropriate.

Web design and marketing agency Leamington Spa